Alana Horowitz

992 total citations · 2 hit papers
10 papers, 612 citations indexed

About

Alana Horowitz is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Alana Horowitz has authored 10 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Alana Horowitz's work include Pulmonary Hypertension Research and Treatments (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Alana Horowitz is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Alana Horowitz collaborates with scholars based in United States, Netherlands and Denmark. Alana Horowitz's co-authors include Saul Villeda, Gregor Bieri, Lucas K. Smith, Adam B. Schroer, Katherine Williams, Kaitlin B. Casaletto, Xuelai Fan, Géraldine Gontier, Joel H. Kramer and Anandharajan Rathinasabapathy and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Alana Horowitz

9 papers receiving 606 citations

Hit Papers

Blood factors transfer beneficial effects of exercise on ... 2020 2026 2022 2024 2020 2023 100 200 300

Peers

Alana Horowitz
Jordan DelFavero United States
Sun Yeul Lee South Korea
Rebecca Persky United States
Claudia Consoli United Kingdom
Alana Horowitz
Citations per year, relative to Alana Horowitz Alana Horowitz (= 1×) peers Miren Revuelta

Countries citing papers authored by Alana Horowitz

Since Specialization
Citations

This map shows the geographic impact of Alana Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alana Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alana Horowitz more than expected).

Fields of papers citing papers by Alana Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alana Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alana Horowitz. The network helps show where Alana Horowitz may publish in the future.

Co-authorship network of co-authors of Alana Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Alana Horowitz. A scholar is included among the top collaborators of Alana Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alana Horowitz. Alana Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bieri, Gregor, et al.. (2026). Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature. Cell. 189(5). 1499–1516.e25.
2.
Schroer, Adam B., Patrick Ventura, Juliana Sucharov, et al.. (2023). Platelet factors attenuate inflammation and rescue cognition in ageing. Nature. 620(7976). 1071–1079. 110 indexed citations breakdown →
3.
Horowitz, Alana, Xuelai Fan, Gregor Bieri, et al.. (2020). Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science. 369(6500). 167–173. 303 indexed citations breakdown →
4.
Smith, Lucas K., Evgenia Verovskaya, Gregor Bieri, et al.. (2020). The aged hematopoietic system promotes hippocampal‐dependent cognitive decline. Aging Cell. 19(8). e13192–e13192. 24 indexed citations
5.
Rathinasabapathy, Anandharajan, Alana Horowitz, Ashok Kumar, et al.. (2018). The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. Frontiers in Physiology. 9. 180–180. 51 indexed citations
6.
Kumar, Ashok, Anandharajan Rathinasabapathy, Alana Horowitz, et al.. (2016). Stimulation of AT 2 Receptor Decreases Collagen Expression and Inhibits Myofibroblast Differentiation to Protect Against Bleomycin‐induced Pulmonary Fibrosis. The FASEB Journal. 30(S1). 1 indexed citations
7.
Rathinasabapathy, Anandharajan, Erin Bruce, Alana Horowitz, et al.. (2016). Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis. British Journal of Pharmacology. 173(19). 2859–2879. 43 indexed citations
8.
Rathinasabapathy, Anandharajan, Alana Horowitz, U. Muscha Steckelings, et al.. (2015). C21, a nonpeptide angiotensin II type 2 receptor agonist attenuates lung fibrosis and associated cardiac dysfunction. PA926–PA926. 2 indexed citations
9.
Shenoy, Vinayak, Tao Yang, Andrés M. Rubiano, et al.. (2015). Abstract 028: ACE2 Activator, Diminazene, Rebalances Gut Microbial Dysbiosis and Attenuates Pulmonary Hypertension. Hypertension. 66(suppl_1). 1 indexed citations
10.
Bruce, Eugene N., Vinayak Shenoy, Anandharajan Rathinasabapathy, et al.. (2014). Selective activation of angiotensinAT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. British Journal of Pharmacology. 172(9). 2219–2231. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026